Dr. David Miller, MD
Claim this profileParkland Memorial Hospital
Expert in Cancer
Studies Ovarian Cancer
20 reported clinical trials
39 drugs studied
About David Miller, MD
Education:
- Earned an MD (Doctor of Medicine) from the University of Oklahoma–Tulsa.
Experience:
- Completed a residency in obstetrics and gynecology at the Medical College of Pennsylvania (now Drexel University College of Medicine).
- Undertook fellowships in reproductive endocrinology and gynecologic oncology at the University of California, San Diego, and Stanford University Medical Center, respectively.
- Board certified in obstetrics and gynecology and gynecologic oncology.
- Has been a faculty member at UT Southwestern since 1991, holding positions such as Chief of the Division of Gynecologic Oncology and Medical Director for the Division of Gynecologic Oncology at the Harold C. Simmons Comprehensive Cancer Center.
- Actively involved in research, clinical trials, and has published several academic articles in the field of gynecologic oncology.
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Ovarian Cancer
Stage IV
BRCA1 positive
Stage III
Affiliated Hospitals
Clinical Trials David Miller, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 1 & 210 criteria
ADP-A2M4CD8 + Nivolumab
for Ovarian Cancer
This trial tests a treatment using modified immune cells alone or with an immune-boosting drug in patients with recurrent ovarian cancer who have a specific genetic marker. The treatment aims to help the immune system better identify and destroy cancer cells.
Recruiting1 award Phase 221 criteria
More about David Miller, MD
Clinical Trial Related2 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments David Miller, MD has experience with
- Selinexor
- Letrozole
- Pembrolizumab
- External Beam Radiation Therapy
- Cisplatin
- Questionnaire Administration
Breakdown of trials David Miller, MD has run
Cancer
Ovarian Cancer
Adenocarcinoma
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Miller, MD specialize in?
David Miller, MD focuses on Cancer and Ovarian Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is David Miller, MD currently recruiting for clinical trials?
Yes, David Miller, MD is currently recruiting for 5 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that David Miller, MD has studied deeply?
Yes, David Miller, MD has studied treatments such as Selinexor, Letrozole, Pembrolizumab.
What is the best way to schedule an appointment with David Miller, MD?
Apply for one of the trials that David Miller, MD is conducting.
What is the office address of David Miller, MD?
The office of David Miller, MD is located at: Parkland Memorial Hospital, Dallas, Texas 75235 United States. This is the address for their practice at the Parkland Memorial Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.